Primary Care Clinics in River Forest, IL Accepting Medicare
15 Primary Care Clinics found. Showing 1 - 15
 Affiliates In Primary Care,s.c. Family Medicine Medicare: Medicare Enrolled Practice Location: 7411 Lake St Ste 2210, River Forest, IL 60305 Phone: 708-450-0055 Fax: 708-450-0288 |
Dhanalakshmi P. Ganesan M.d.s.c Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7357 North Ave, River Forest, IL 60305 Phone: 708-405-6200 Fax: 708-405-6223 |
Dr Mary Kelly Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7319 North Ave, River Forest, IL 60305 Phone: 708-848-0040 |
S.s. Shroff, M.d.,s.c. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7355 North Ave, River Forest, IL 60305 Phone: 708-484-1411 Fax: 708-484-1468 |
River Grove Medical Partners, Ltd Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7355 North Ave, River Forest, IL 60305 Phone: 708-771-0921 Fax: 708-771-0925 |
River Forest Medical Associates Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7353 North Ave, River Forest, IL 60305 Phone: 708-771-6611 Fax: 708-771-6335 |
Locke & Uchitelle Pc Family Medicine Medicare: Medicare Enrolled Practice Location: 7411 Lake St, Ste 2210, River Forest, IL 60305 Phone: 708-366-8200 Fax: 708-366-8938 |
William J Sarantos,md Internal Medicine Medicare: Medicare Enrolled Practice Location: 7353 North Ave, River Forest, IL 60305 Phone: 708-867-6087 Fax: 708-867-6032 |
Wellness Center Clinic/Center - Student Health Medicare: Not Enrolled in Medicare Practice Location: 7900 Division St, River Forest, IL 60305 Phone: 708-524-6229 Fax: 708-488-5072 |
Asad A Bakir Mdsc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1112 Lathrop Ave, River Forest, IL 60305 Phone: 708-937-1060 |
The Holistic Bodylab Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 7353 Lake St, River Forest, IL 60305 Phone: 312-307-4458 |
Chmg - River Forest Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7411 Lake St Ste 1120, River Forest, IL 60305 Phone: 844-533-2464 |
Teresa Mckenzie, M.d., Llc Internal Medicine Medicare: Medicare Enrolled Practice Location: 7605 1/2 North Ave, River Forest, IL 60305 Phone: 708-366-4888 |
Internal Medicine Center Of Oak Park And River Forest Sc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7411 Lake St, Ste L120, River Forest, IL 60305 Phone: 708-488-1919 Fax: 708-488-2370 |
Integrative Therapies, Ltd. Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 7756 Madison St, Suite 8, River Forest, IL 60305 Phone: 708-771-3471 Fax: 708-771-2553 |
News Archive
DOJ investigates alleged fraud by drugmakers; sanctions on wellcare lifted
"A $112 million settlement involving alleged drug kickbacks that the Justice Dept. announced with the nation's largest nursing home pharmacy and a generic drug manufacturer on Nov. 3 is part of a wide-ranging investigation of suspected Medicaid fraud by the pharmaceutical industry," Business Week reports. "Critics say the continuing probe, which involves Johnson & Johnson (JNJ) and other major drugmakers, highlights what they describe as an industry practice of paying money to outfits that provide drugs to consumers, in return for preferential treatment."
Military deployment influences sleep quality and quantity
A study in the Dec. 1 issue of the journal SLEEP found that deployment to Iraq and Afghanistan significantly influenced sleep quality and quantity in a population of 41,225 military service personnel. The study suggests that the promotion of healthier sleep patterns may be beneficial for military service members.
Shire receives Paragraph IV Notice Letter over generic INTUNIV ANDAs from Teva Pharmaceuticals
Shire plc, announces that it has received a Paragraph IV Notice Letter from Teva Pharmaceuticals USA, Inc. advising of the filing of an Abbreviated New Drug Application for a generic version of Shire's 1 mg, 2mg, 3 mg, and 4mg guanfacine hydrochloride extended release tablets, INTUNIV(TM).
Gilead Sciences announces positive results from LDV/SOF phase 2 studies on HCV infection
Gilead Sciences, Inc. (Nasdaq: GILD) today announced data from two Phase 2 studies evaluating investigational all-oral regimens containing the nucleotide analog polymerase inhibitor sofosbuvir (SOF) for the treatment of chronic hepatitis C virus (HCV) infection.
Halozyme Therapeutics receives FDA clearance for Cumulase
Halozyme Therapeutics has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Cumulase for the treatment of oocytes to facilitate certain in vitro fertilization (IVF) procedures. The active pharmaceutical ingredient in Cumulase is the first and only recombinant human hyaluronidase approved in the United States for cumulus removal in the IVF process.
› Verified 2 days ago